These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25685868)

  • 21. Does community-wide chronic kidney disease management improve patient outcomes?
    Rayner HC; Baharani J; Dasgupta I; Suresh V; Temple RM; Thomas ME; Smith SA
    Nephrol Dial Transplant; 2014 Mar; 29(3):644-9. PubMed ID: 24335381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promotion of kidney care in countries with limited resources: How does the National Kidney Foundation of South Africa fare?
    Meyers AM
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):69-73. PubMed ID: 27469152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Averting the Legacy of Kidney Disease - Focus on Childhood.
    Ingelfinger JR; Kalantar-Zadeh K; Schaefer F;
    Blood Purif; 2016; 41(4):332-8. PubMed ID: 26930219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing CKD risks among vulnerable populations in primary care.
    Greer R; Boulware LE
    Adv Chronic Kidney Dis; 2015 Jan; 22(1):74-80. PubMed ID: 25573516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney health for everyone everywhere - from prevention to detection and equitable access to care.
    Kam-Tao Li P; Garcia-Garcia G; Lui SF; Andreoli S; Wing-Shing Fung W; Hradsky A; Kumaraswami L; Liakopoulos V; Rakhimova Z; Saadi G; Strani L; Ulasi I; Kalantar-Zadeh K
    Arch Argent Pediatr; 2020 Apr; 118(2):e148. PubMed ID: 32199054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden, access, and disparities in kidney disease.
    Crews DC; Bello AK; Saadi G
    Clin Nephrol; 2019 Mar; 91(3):129-137. PubMed ID: 30704553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early-life course socioeconomic factors and chronic kidney disease.
    Brophy PD; Shoham DA; ; Charlton JR; Carmody J; Reidy KJ; Harshman L; Segar J; Askenazi D
    Adv Chronic Kidney Dis; 2015 Jan; 22(1):16-23. PubMed ID: 25573508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and risk factors of chronic kidney disease in the El-Sharkia Governorate, Egypt.
    Ghonemy TA; Farag SE; Soliman SA; El-okely A; El-hendy Y
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):111-7. PubMed ID: 26787576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrology in Africa - challenges of practice in resource-limited environment.
    Naicker S
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):84-89. PubMed ID: 27469153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic kidney disease care in the US safety net.
    Tuot DS; Grubbs V
    Adv Chronic Kidney Dis; 2015 Jan; 22(1):66-73. PubMed ID: 25573515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of the Fittest: Addressing the Disparities in the Burden of Chronic Kidney Disease.
    Nelson ML; Buchanan-Peart KR; Oribhabor GI; Khokale RV; Cancarevic I
    Cureus; 2020 Jul; 12(7):e9499. PubMed ID: 32879822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Need for chronic kidney disease prevention programs in disadvantaged populations.
    Perico N; Remuzzi G
    Clin Nephrol; 2015; 83(7 Suppl 1):42-8. PubMed ID: 25725241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CKD Hotspots: Challenges and Areas of Opportunity.
    Obrador GT; Levin A
    Semin Nephrol; 2019 May; 39(3):308-314. PubMed ID: 31054631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Food Insecurity, CKD, and Subsequent ESRD in US Adults.
    Banerjee T; Crews DC; Wesson DE; Dharmarajan S; Saran R; Ríos Burrows N; Saydah S; Powe NR;
    Am J Kidney Dis; 2017 Jul; 70(1):38-47. PubMed ID: 28215947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.
    Bowe B; Xie Y; Xian H; Li T; Al-Aly Z
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):603-613. PubMed ID: 28348030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
    Weir MR; Fink JC
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):306-13. PubMed ID: 24670404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention programs for chronic kidney disease in low-income countries.
    Perico N; Remuzzi G
    Intern Emerg Med; 2016 Apr; 11(3):385-9. PubMed ID: 26983956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Rights of Patients with Chronic Kidney Disease in the World: Legal Perspectives and Challenges in Brazil, India, Portugal, South Africa, and Nigeria.
    Assis Buosi AP; Paturkar D; Dias ER; Estorninho MJ; Kolawole O; Ghooi R; Lutchman S
    Contrib Nephrol; 2021; 199():322-338. PubMed ID: 34344007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the management of chronic kidney disease in Uruguay: a National Renal Healthcare Program.
    Schwedt E; Solá L; Ríos PG; Mazzuchi N;
    Nephron Clin Pract; 2010; 114(1):c47-59. PubMed ID: 19816043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.